• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Neupogen (Filgrastim)

Audience: Oncologists and other healthcare professionals, pharmacists, wholesalers

Amgen Inc. recently became aware of the existence in the U.S. of a counterfeit drug product labeled as Neupogen® 300 mcg vials in ten- pack boxes. In cooperation with the FDA, Amgen is informing patients, physicians, pharmacies, and wholesalers about this serious health risk. The Amgen web page referenced below includes detailed descriptions, along with comparison photos of the authentic and the counterfeited product.

[May 10, 2001 - Counterfeit Alert - Amgen Inc. web page]